News and Announcements
Case Studies of Analytica’s PeriCoach Published in Peer Reviewed Urology Journal
- Published May 20, 2016 10:20AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
19th May 2016, ASX Announcement
Analytica Ltd (ASX: ALT) manufacturer of the PeriCoach® System is pleased announce the publication of case studies describing pelvic floor training with Pericoach in the Urologic Nursing Journal of the US Society of Urologic Nurses and Associates.
Clinical support and publication in a leading peer review journal is a significant milestone for the Company and is a direct reflection of executing its strategy to obtain clinical evidence of PeriCoach.
The journal articles are authorised by US Nurse Practitioner (NP) Julie Starr and Physiotherapist (PT) Beth Shelley. The articles are based on two separate case studies which were conducted to demonstrate the efficacy and ease of the use of PeriCoach in the treatment of common pelvic floor dysfunctions such as urinary incontinence and pelvic organ prolapse, as well as the emotional and lifestyle benefits of restoring pelvic floor strength.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
